Breast Health News
|
|
|
For the latest information on breast cancer and the impact this life-threatening disease continues to have across the world, consider this your primary resource. Our spokespeople and grassroots networks of millions work tirelessly to make a difference while putting a face to every news story. As the leading news source for breast cancer developments, statistics, trends, commentary, photos and video, we continually update the news-related content in order to keep you informed.
|
|
|
Lynch Syndrome Also Linked with Breast and Pancreatic Cancer
A study of families with Lynch Syndrome has expanded the list of cancers related to the condition carriers of a Lynch Syndrome gene mutation also appear to have an increased risk of breast cancer and pancreatic cancer. These results were ...
|
|
Outcomes in Older Women with Breast Cancer
Among postmenopausal women with hormone receptor positive breast cancer, the likelihood of dying from breast cancer increases with age. These results were published in the Journal of the American Medical Association. Of the more than 200,000 cases of breast ...
|
|
Aromasin Provides Breast Benefit But Takes a Toll on Bone
Among healthy postmenopausal women at increased risk of breast cancer, the aromatase inhibitor Aromasin® (exemestane) reduces the risk of breast cancer but also increases bone loss. These results were published in Lancet Oncology. Drugs that block the effects of estrogen ...
|
|
Rates of Repeat Breast Cancer Surgery Vary Widely
Among women who undergo breast conserving surgery for invasive breast cancer, the likelihood of having a second surgery varies by institution and by surgeon. These results were published in the Journal of the American Medical Association. Breast conserving surgery (also ...
|
|
Avastin May Improve Breast Cancer Response Rates
Among women with HER2 negative breast cancer that has not spread to distant sites in the body, the addition of Avastin to neoadjuvant (before surgery) chemotherapy may increase the likelihood of a complete response to treatment (a disappearance of detectable ...
|
|
Ovarian Suppression During Chemotherapy Fails to Improve Post-Treatment Menstrual Function
Among young women undergoing chemotherapy for breast cancer, use of the drug triptorelin to suppress ovarian function during treatment does not appear to improve post treatment menstrual function. These results were published in the Journal of Clinical Oncology. Fertility preservation ...
|
|
Oncotype DX DCIS Score Predicts Recurrence Risk for Women with DCIS
A DCIS Score generated by the Oncotype DX breast cancer test provides information about how likely it is that breast ductal carcinoma in situ (DCIS) will recur. This may help guide decisions about whether women with DCIS need radiation therapy ...
|
|
Breast Brachytherapy Linked with More Complications and Higher Mastectomy Rate
Among women with early stage breast cancer, use of brachytherapy to administer radiation therapy may result in more post operative complications than conventional external beam radiation therapy, and may also increase the likelihood that a woman will later require a ...
|
|
Combined HER2 Treatment Improves Outcome of Advanced Breast Cancer
Among women with metastatic, HER2 positive breast cancer, treatment with a combination of HER2 targeted therapies may produce better outcomes than treatment with only a single HER2 targeted therapy. These results were published in the New England Journal of Medicine ...
|
|
Afinitor Delays Breast Cancer Progression
Among postmenopausal women with advanced breast cancer that had become resistant to hormonal therapy, the combination of Afinitor® (everolimus) and Aromasin® (exemestane) delayed cancer progression to a greater extent than Aromasin alone. The results of this Phase III clinical trial ...
|
|
Longer Follow-Up Continues to Suggest That Zometa May Provide Breast Cancer Benefit
Longer term follow of of the ABCSG 12 study continues to suggest that the bisphosphonate drug Zometa® (zoledronic acid) may improve outcomes among women with early stage, hormone receptor positive breast cancer. These results were presented at the 2011 CTRC ...
|
|
Herceptin Given At Same Time As Chemotherapy May Provide Most Benefit for Breast Cancer
The results of a Phase III clinical trial suggest that starting Herceptin® (trastuzumab) during chemotherapy for early stage, HER2 positive breast cancer may be more effective than starting Herceptin after chemotherapy has been completed. These results were published in the ...
|
|
FDA Revokes Avastin’s Approval for Breast Cancer
The US Food and Drug Administration (FDA) is revoking the approval of Avastin® (bevacizumab) for the treatment of advanced breast cancer. This decision does not affect the use of Avastin for other approved purposes. Avastin is a targeted therapy that ...
|
|
Even Low Levels of Alcohol Slightly Increase Breast Cancer Risk
Women who have as few as three to six alcoholic beverages per week have a slightly increased risk of breast cancer. Heavier drinker further increases risk. These results were published in the Journal of the American Medical Association. Many previous ...
|
|
Additional Treatment With Femara After Five Years of Tamoxifen May Improve Overall Survival Among Women with Early Breast Cancer
Among postmenopausal women who complete five years of tamoxifen for the treatment of early stage breast cancer, an additional five years of treatment with the aromatase inhibitor Femara® (letrozole) may improve overall survival. These results were published in the Journal ...
|
|
Femara Results in Lower Risk of Breast Cancer Recurrence Than Tamoxifen
Among postmenopausal women with early stage, hormone receptor positive breast cancer, five years of hormonal therapy with Femara® (letrozole) results in a lower risk of cancer recurrence than five years of tamoxifen. These results were published in Lancet Oncology. The ...
|
|
A BRCA Gene Mutation in the Family Does Not Increase Cancer Risk for Those Without the Mutation
For women who do not have a BRCA1 or BRCA2 gene mutation, having a close relative with one of these mutations does not increase breast cancer risk. These results were published in the Journal of Clinical Oncology. Inherited mutations in ...
|
|
More Sensitive Testing of Sentinel Nodes Does Not Appear Necessary
For breast cancer patients with a sentinel lymph node that appears free of cancer based on standard testing (hematoxylin eosin staining), detection of very small areas of cancer in the lymph node through additional, more sensitive testing (immunohistochemistry) does not ...
|
|
Additional Evidence That Post-Lumpectomy Radiation Improves Breast Cancer Outcomes
In addition to reducing the risk of breast cancer recurrence, post lumpectomy radiation therapy improves survival among women with early breast cancer. These results—from a combined analysis of 17 previous studies—were published in The Lancet. Surgery for early stage breast ...
|
|
False-Positive Results Common with Annual Screening Mammography
Among women who start annual screening mammography at the age of 40, more than half will have a false positive result (the need to return for additional imaging even though no cancer is present) during the first 10 years of ...
|
| > more... |
